BridgeBio Pharma Inc.

About BridgeBio Pharma Inc.

BridgeBio is a biotechnology company focused on designing transformative medicines for patients with genetic diseases. Their mission is to bridge the gap between advancements in genetic science and unmet patient needs through rigorous science and a novel drug development approach.

Products & Services

Attruby™ (acoramidis):A medicine designed for patients, with further details available on the dedicated website.

Specialties

Genetic Diseases Transformative Medicines Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 550000000 MR: - FA: $550 million FAN: 550000000	D: 2026-01-15 FD: 2026-01-15	-
2	RT: Convertible Debt T: - FT: Convertible Debt	A: 550000000 MR: - FA: $550 million FAN: 550000000	D: 2026-01-14 FD: 2026-01-14	-
3	RT: Royalty Financing T: - FT: Royalty Financing	A: 300000000 MR: - FA: 300 million FAN: 300000000	D: 2025-06-30 FD: 2025-06-30	2 investors
4	RT: Debt T: - FT: Debt	A: 500000000 MR: - FA: 500 million USD FAN: 500000000	D: 2025-02-25 FD: 2025-02-25	-
5	RT: Convertible Senior Notes T: - FT: Convertible Senior Notes	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2025-02-24 FD: 2025-02-24	-
6	RT: Public Offering T: - FT: Public Offering	A: 250000000 MR: - FA: approximately $250.0 million FAN: 250000000	D: 2024-03-05 FD: 2024-03-05	4 investors
7	RT: Public Offering T: - FT: Public Offering	A: 250000000 MR: - FA: $250 million FAN: 250000000	D: 2024-03-04 FD: 2024-03-04	4 investors
8	RT: Royalty Financing and Debt T: - FT: Royalty Financing and Debt	A: 1250000000 MR: - FA: up to $1.25 billion FAN: 1250000000	D: 2024-01-18 FD: 2024-01-18	2 investors
9	RT: PIPE T: - FT: PIPE	A: 250000000 MR: - FA: $250 million FAN: 250000000	D: 2023-09-25 FD: 2023-09-25	4 investors
10	RT: Public Offering T: - FT: Public Offering	A: 150000000 MR: - FA: approximately $150 million FAN: 150000000	D: 2023-03-08 FD: 2023-03-08	4 investors
11	RT: Public Offering T: - FT: Public Offering	A: 150000000 MR: - FA: $150 million FAN: 150000000	D: 2023-03-06 FD: 2023-03-06	3 investors

Debt Latest

2026-01-15

$550.0M

Convertible Debt 2026-01-14

$550.0M

Royalty Financing 2025-06-30

$300.0M

View 10 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alexis

E

Elliott

Living with MoCD Type A

M

Miguel Carrillo

T

Tobin

Girl with Canavan Disease

A

Aaron Argenta

A

Aaron Daugherty

View 741 more team members with Pro

Unlock Full Team Directory

Recent News